MarketInOut Stock Screener Log In | Sign Up
 

Merck & Co Inc

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 05/12/2026 16:00
Merck & Co Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization275,089 mln
Float2,466 mln
Earnings Date08/04/2026

EPS

3.55
Stretched

P / E

31.65
Overvalued

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.27
Borderline

1-Year Forecast

130
Attractive

Relative Strength

65 / 100
Outperforming

Business Description

Merck & Co. is a global healthcare company founded in 1891 and based in Rahway, New Jersey, that develops and sells a wide range of medicines and vaccines for both people and animals. Its human health products cover areas such as cancer, infectious disease, and sleep disorders, while its animal health division serves livestock farmers and pet owners with treatments, vaccines, and monitoring tools. The company also works alongside several partners, including AstraZeneca, Eisai, Bayer, and Moderna, to bring new treatments to market across a variety of disease areas.

Key Fundamentals

EPS3.55
P/E31.65
ROE18.01
RPS26.39
ROIC11.64
ROA7.25
Interest Cover12.44
EBITDA, mln17,745
EV / EBITDA17.17
EV / EBIT23.43
Revenue, mln65,768
EV / Revenue4.63

Financial Strength

Altman Z-Score3.82
Piotroski F-Score 4 / 9
Beneish M-Score-2.27
Price to Intrinsic Value1.48
Price to Lynch Fair Value0.78
Price to Graham Number5.92
1-Year Target Price130
Shiller PE Ratio26.45
Short Ratio2.82
Short % of Float1.11

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.69% 32 / 100   
1 Month -6.48% 12 / 100   
2 Months -2.28% 27 / 100   
6 Months 32.32% 88 / 100   
1 Year 53.28% 85 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us